B cell–derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity
Year: 2017
Type: article
Abstract: Recent studies have identified critical roles for B cells in triggering autoimmune germinal centers (GCs) in systemic lupus erythematosus (SLE) and other disorders. The mechanisms whereby B cells facilitate loss of T cell tolerance, however, remain incompletely defined. Activated B cells produce interleukin 6 (IL-6), a proinflammatory cytokine that promotes T follicular helper (TFH) cell differentiation. Although B cell IL-6 production correlates with disease severity in humoral autoimmunity, whether B cell–derived IL-6 is required to trigger autoimmune GCs has not, to our knowledge, been addressed. Here, we report the unexpected finding that a lack of B cell–derived IL-6 abrogates spontaneous GC formation in mouse SLE, resulting in loss of class-switched autoantibodies and protection from systemic autoimmunity. Mechanistically, B cell IL-6 production was enhanced by IFN-γ, consistent with the critical roles for B cell–intrinsic IFN-γ receptor signals in driving autoimmune GC formation. Together, these findings identify a key mechanism whereby B cells drive autoimmunity via local IL-6 production required for TFH differentiation and autoimmune GC formation.
DOI: 10.1084/jem.20170580
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funders: American College of Rheumatology Research and Education Foundation, Arthritis National Research Foundation, Alliance for Lupus Research, Lupus Research Alliance, National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Awards: B cell-intrinsic cytokine regulation and B cell-targeted therapies in murine lupu, Defining the functional impact of T1D genes in mouse and man: a unified strategy, An integrated strategy to define the functional and synergistic impact of T1D causal variants, Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome, Research Training in Rheumatology
OpenAlex ID: W2755000263
